
Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader. Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1 | 7.09219858156 | 1.41 | 1.62 | 1.22 | 71931 | 1.376186 | CS |
4 | 0.07 | 4.86111111111 | 1.44 | 1.67 | 1.22 | 38036 | 1.43123016 | CS |
12 | -0.01 | -0.657894736842 | 1.52 | 2.35 | 1.22 | 336322 | 1.66784844 | CS |
26 | -1.49 | -49.6666666667 | 3 | 7.2 | 1.22 | 1355311 | 2.61458325 | CS |
52 | -3.1236 | -67.4119475138 | 4.6336 | 7.2 | 1.22 | 726010 | 2.6975882 | CS |
156 | -106.49 | -98.6018518519 | 108 | 113.34 | 1.22 | 461891 | 24.059645 | CS |
260 | -790.49 | -99.8093434343 | 792 | 820 | 1.22 | 680439 | 176.74387797 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約